EGRX Stock Predictions
| Recent EGRX Stock Price | EGRX Stock Predictions | |
| $49.03 |  +1.31% |
$49.67 |
| Recent EGRX Analyst Ratings Breakdown, Making EGRX Stock Predictions | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 1 | 1 | 0 | 1 |
| Buy ratings: | 1 | 1 | 1 | 1 |
| Hold ratings: | 2 | 2 | 2 | 2 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 2.25 | 2.25 | 2.67 | 2.25 |
For the EGRX stock predictions from the analysts covering Eagle Pharmaceuticals, Inc., we have collected all of the individual EGRX stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 3 different analysts covering EGRX (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since EGRX stock predictions may vary widely, another useful metric to consider is the median EGRX stock prediction, which represents the price at which half of the analysts
made EGRX stock predictions that were higher and half made EGRX stock predictions that were lower. This makes for a different take on the EGRX stock predictions out there, as compared to average or mean.
And that median across all the individual EGRX stock predictions was: $51.0 as of 2021-09-20.
The very highest of the EGRX stock predictions for one year price target was $52.0, while the very lowest of the EGRX stock predictions in the analyst group was
$46.0 (with a standard deviation of $3.214). Get the latest Zacks research report on EGRX — FREE
Find out: EGRX next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
• CNO Stock Predictions
• HUBS Stock Predictions
• ORBC Stock Predictions
• ATNX Stock Predictions
• LQDT Stock Predictions
• IRCP Stock Predictions
• EXPE Stock Predictions
• ABBV Stock Predictions
• FOSL Stock Predictions
|
|||||||||
|
|
|
|
|
|
Avg. Broker Rec.
 
|
Buy (2.75 out of 4) 16th percentile
(ranked lower than approx. 84% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
